Ventricular Assist Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Ventricular Assist Device Market Trends & Companies and the market is segmented by Type of Ventricular Device (Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)), Application (Bridge-to-transplant (BTT) therapy, Destination therapy, and Other Therapies), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Ventricular Assist Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Ventricular Assist Device Industry Overview

The ventricular assist device market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising geriatric population and high prevalence of diseases, few other smaller players are expected to enter into the market in the coming years. Some of the major players of the market are Abiomed Inc., BiVACOR Inc, Abbott Laboratories (St. Jude Medical Inc.), Medtronic PLC, and Terumo Corporation, among others.

Ventricular Assist Device Market Leaders

  1. Abiomed Inc.

  2. BiVACOR Inc.

  3. Abbott Laboratories (St. Jude Medical Inc.)

  4. Medtronic PLC

  5. Terumo Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Ventricular Assist Device Market Concentration

Ventricular Assist Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?